Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

RATIONALE: Vaccines made from breast cancer cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccines made from breast cancer cells in treating women with metastatic breast cancer.

Key facts

Study ID

NCT00003184

Run by

Providence Cancer Center, Earle A. Chiles Research Institute

Starts

1996-08-01

Expected to finish

2003-07-01

Last updated by the study team

2013-04-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Earle A. Chiles Research Institute at Providence Portland Medical Center — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.